Decoding coupled epigenetic-fragmentomic signals in circulating cell-free DNA for interpretable cancer diagnosis.
Researchers show that blood-based methylation patterns can preserve hidden signals for detecting cancer, potentially enabling simpler screening pathways.
This study evaluated whether cell-free DNA whole-genome methylation sequencing preserves fragmentomic signals for cancer detection. The results support plasma methylation haplotype blocks as interpretable units for integrating complementary methylation and fragmentation information.
What the study was
- Study design
- Prospective multi-modal validation study
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Genome medicine
Why it surfaced
High triage score (9/10) based on study design (Prospective multi-modal validation study) and direct clinical relevance; matched topic: Early cancer detection (liquid biopsy, ctDNA, cfDNA); flag: 🔴 Early cancer detection or prevention
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.